HCPCS Level II code A6025 designates a single gel sheet for dermal or epidermal application (for example, silicone or hydrogel). The code identifies a commonly used topical supply for wound management and scar care across outpatient and home-health settings. Nationally, A6025 matters because it standardizes billing for discrete skin-contact gel sheets used in routine wound and dermatologic care, affecting coverage determinations and supply utilization.

Key payers discussed include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of the clinical purpose of the item, typical sites of service, and the payment and coding context relevant to major national payers. The publication summarizes benchmarking approaches, payer coverage patterns, and common billing considerations for this supply item. It also outlines the clinical scenarios in which a gel sheet is employed and identifies areas where policy updates or documentation practices can influence claim adjudication.

This summary is intended for clinicians, coding professionals, and revenue cycle staff seeking a national perspective on billing and coverage considerations for HCPCS Level II code A6025.